Skip to main content
. 2014 Jun 24;9(6):e99484. doi: 10.1371/journal.pone.0099484

Figure 4. hCAR characterization in two NSCLC independent studies.

Figure 4

(A) Genetic alterations and frequency of hCAR in the Lung Adenocarcinoma study available from TCGA. (B) Same data from the Lung Squamous Cell Carcinoma study available from TCGA. (C) DNA methylation vs gene expression of hCAR from Lung Adenocarcinoma samples from TCGA. (D) DNA methylation vs gene expression of hCAR from Lung Squamous Cell Carcinoma samples from TCGA. Both datasets presented highly DNA methylation and variable levels of mRNA expression of NR1I3.